Skip to main content
FinSpry Logo
FinSpry
EDIT logo
EDIT
(NASDAQ)
Editas Medicine, Inc.
$2.67-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Editas Medicine (EDIT) Stock Price & Financial Analysis

Editas Medicine Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.53 - $2.69
52-Week High$4.54
52-Week Low$0.91
Open$2.57
Volume1.12M
Average Volume (3M)1.12M
Market Cap236.95M
Shares Outstanding88.75M
Price to Sales (P/S)5.72
Price to Book (P/B)8.49
Revenue (TTM)40.52M
Net Income (TTM)-160.06M
Free Cash Flow (TTM)-165.70M
EPS (TTM)$-1.80
Profit Margin-395.01%
Operating Margin-79.96%
Return on Equity (ROE)-586.56%
Debt to Equity1.11
50-Day MA$2.13
200-Day MA$2.59
52-Week Change130.97%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Editas Medicine

What is the current stock price for EDIT?

As of the latest trading session, EDIT stock trades at $2.67. The 52-week range is $0.91–$4.54, with a day range of $2.53–$2.69.

What is the P/E ratio for EDIT?

The P/E ratio (Price-to-Earnings) for EDIT is shown in the Key Statistics section. This valuation metric helps compare Editas Medicine, Inc. to industry peers.

Does EDIT pay dividends?

Editas Medicine does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EDIT?

Based on 5 analysts, the consensus for EDIT is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of EDIT?

Editas Medicine's market capitalization is $237.0M, classifying it as a micro-cap company. Editas Medicine operates in the Healthcare sector within the Biotechnology industry.